Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure
Journal of Viral Hepatitis · 2024
DOI: 10.1111/jvh.14009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Helen L Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Sustained Virologic Response, Hepatitis C, Chronic, Antiviral Agents, Alanine Transaminase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: NIH-NCATS UL1TR002553, NIH-NIAID T32-AI055435, NIH-NIAID R25AI140495.
Abstract (Originalsprache)
A subset of patients with chronic hepatitis C virus (HCV) infection demonstrate liver enzyme elevation (LEE) after achieving sustained virologic response (SVR). Risk factors for LEE are not well characterised. We conducted a single‐centre retrospective cohort study of adults with HCV infection in the Duke University Health System who received direct‐acting antiviral therapy and achieved SVR. We performed multivariable logistic regression to assess the relationship between potential risk factors and LEE. We used generalised linear mixed‐effects models to explore longitudinal relationships between HIV and LEE. Among 1356 patients, 556 (41.0%) had LEE after achieving SVR. Higher pretreatment alanine aminotransferase (ALT) (adjusted odds ratio [aOR] 1.08 per 10 IU/L increase; 95% confidence interval [CI] 1.05–1.11) and pretreatment cirrhosis (aOR 2.26, 95% CI 1.60–3.21) were associated with higher odds of LEE; male sex was associated with lower odds of LEE (aOR 0.28, 95% CI 0.21–0.38). There was insufficient evidence of an association between HIV and LEE (aOR 0.83, 95% CI 0.47–1.44). Pretreatment ALT, cirrhosis and female sex predicted LEE in this cohort of patients with HCV infection who achieved SVR. These findings can help to identify patients at greatest risk of post‐SVR liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Clinical Research Institute, Durham, North Carolina, USA.
ORCID-Profile: E Wilbur Woodhouse
Förderung
- NIH-NCATS UL1TR002553
- NIH-NIAID T32-AI055435
- NIH-NIAID R25AI140495
- NIH 5P30 AI064518
Zitieren
APA
Zhang, H. L., Nemeth, H., Woodhouse, E. W., Davenport, C. A., Chan, C., Okeke, N. L., & Naggie, S. (2024). Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.14009
Vancouver
Zhang HL, Nemeth H, Woodhouse EW, Davenport CA, Chan C, Okeke NL, et al. Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.14009
BibTeX
@article{Zhang2024,
author = {Zhang, Helen L and Nemeth, Hayley and Woodhouse, E Wilbur and Davenport, Clemontina A and Chan, Cliburn and Okeke, Nwora Lance and Naggie, Susanna},
title = {Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure},
journal = {Journal of Viral Hepatitis},
year = {2024},
doi = {10.1111/jvh.14009}
}
EUVIMED